About the Company

About the Company

Lifescient was established by Kamalesh Rao, who has 25 years of expertise in pharmaceutical development. Rao played a pivotal role on the team that successfully created a sustained-release injectable to alleviate symptoms of opioid withdrawal in humans. Upon the approval of this groundbreaking product, Rao envisioned the potential application of this technology in veterinary medicine.

Since 2018, we have developed several prototypes of LAIs to treat chronic conditions in animals. In 2020, due to the unfortunate circumstances of the pandemic, all research at our service providers came to a halt. During this period we spent time exploring  medications to add to our portfolio that would be suitable to treat chronic conditions in our pets. We conducted surveys of veterinarians across the US and based on the responses began development of LS-001, a long-acting analgesic to control pain caused from bone cancer in dogs. 

In 2023, a request for a fee waiver was submitted to the FDA to support the advancement of LS-001’s development, which was approved. Subsequently, marking a significant milestone, the FDA granted the Company’s request to open an Investigational New Animal Drug file for this product.

Assembling a team of dedicated professionals driven by the mission to enhance animal well-being, Lifescient stands as a pioneer in drug delivery advancements focused on improving the quality of healthcare for pets and the quality of life for those who love and care for them.

The Team

The Team

Kamalesh Rao

Kamalesh Rao

Founder and CEO

Kamalesh has over 25 years of experience in the development of pharmaceuticals and product approvals. He played a pivotal role in the chemical development of Probuphine®, the first ever LAI formulation to deliver long-lasting medication to treat people addicted to opioids. Kamalesh has experience in the development of sustained release, long-acting injectable and long-acting solid and in situ gel implant dosage forms. He is an avid hiker, and  is a certified yoga instructor.

Renee Sera

Renee Sera

Chief Administrative Officer

Renee is a small business owner, real estate developer and angel investor. She started her path at Lifescient as a consultant and was responsible for marketing and business development and has since expanded her role with the Company. She loves to cook for friends and family and enjoys winter sports.

Dr. Mari Delaney

Dr. Mari Delaney

Scientific Advisor

Dr. Delaney, a graduate of  the Cornell University College of Veterinary Medicine has been practicing small animal medicine and surgery since 1995. Her interests lie in preventative medicine and it is this dedication that led to her development of VetProtect, an easily accessible tool to help prevent accidental poisonings of pets. Dr. Delaney’s focus is to develop tools for pet parents that allow for high-quality care and strengthen pet and pet parent bond.

Dr. Craig Miller

Dr. Craig Miller

Scientific Advisor

Dr. Craig Miller is a veterinarian with more than 20 years of experience in small animal clinical practice. He has a background in animal health research, including field studies, toxicology, and parasitism. Dr. Miller received his undergraduate degree from Knox College and his DVM degree from the University of Illinois College of Veterinary Medicine. His areas of expertise include preventative medicine, dentistry, soft tissue surgery, and pain management.

Amy Berlin

Amy Berlin

Project Manager

Amy has over 25 years experience in business analysis and finance operations in the telecommunications industry. She spent 10 years in regulatory operations. She joined our team as Project Manager to help develop various programs in the business. In her free time she’s playing the blues on her red electric guitar.

Daniele Campos

Daniele Campos

Business Development

Daniele Santos has worked for over 12 years in the administrative and financial management field. She has experience in due diligence and has participated in the IPO process of companies in the Brazilian and Canadian markets. She is experienced in foreign trade and has a postgraduate degree and an MBA in financial management, controllership and auditing. Daniele has traveled the world and is fluent in Portuguese.